Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans: a placebo-controlled study

To characterise the comparative potency of optically pure (R)- and (S)-verapamil as regards negative dromotropic effects on atrioventricular (AV) node conduction and to compare the hemodynamic effects of single doses of the enantiomers in healthy volunteers.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Busse, Dagmar (VerfasserIn) , Templin, Silke (VerfasserIn) , Mikus, Gerd (VerfasserIn) , Schwab, Matthias (VerfasserIn) , Hofmann, Ute (VerfasserIn) , Eichelbaum, Michel (VerfasserIn) , Kivistö, Kari T. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 4 July 2006
In: European journal of clinical pharmacology
Year: 2006, Jahrgang: 62, Heft: 8, Pages: 613-619
ISSN:1432-1041
DOI:10.1007/s00228-006-0154-7
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00228-006-0154-7
Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007%2Fs00228-006-0154-7
Volltext
Verfasserangaben:Dagmar Busse, Silke Templin, Gerd Mikus, Matthias Schwab, Ute Hofmann, Michel Eichelbaum, Kari T. Kivistö

MARC

LEADER 00000caa a2200000 c 4500
001 1772741833
003 DE-627
005 20230426091823.0
007 cr uuu---uuuuu
008 211007s2006 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00228-006-0154-7  |2 doi 
035 |a (DE-627)1772741833 
035 |a (DE-599)KXP1772741833 
035 |a (OCoLC)1341421548 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Busse, Dagmar  |d 1965-  |e VerfasserIn  |0 (DE-588)11819190X  |0 (DE-627)694749966  |0 (DE-576)291761445  |4 aut 
245 1 0 |a Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans  |b a placebo-controlled study  |c Dagmar Busse, Silke Templin, Gerd Mikus, Matthias Schwab, Ute Hofmann, Michel Eichelbaum, Kari T. Kivistö 
264 1 |c 4 July 2006 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.10.2021 
520 |a To characterise the comparative potency of optically pure (R)- and (S)-verapamil as regards negative dromotropic effects on atrioventricular (AV) node conduction and to compare the hemodynamic effects of single doses of the enantiomers in healthy volunteers. 
700 1 |a Templin, Silke  |e VerfasserIn  |4 aut 
700 1 |a Mikus, Gerd  |e VerfasserIn  |0 (DE-588)110903137  |0 (DE-627)691097941  |0 (DE-576)336988710  |4 aut 
700 1 |a Schwab, Matthias  |e VerfasserIn  |4 aut 
700 1 |a Hofmann, Ute  |e VerfasserIn  |4 aut 
700 1 |a Eichelbaum, Michel  |e VerfasserIn  |4 aut 
700 1 |a Kivistö, Kari T.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t European journal of clinical pharmacology  |d Berlin : Springer, 1968  |g 62(2006), 8, Seite 613-619  |h Online-Ressource  |w (DE-627)253722829  |w (DE-600)1459058-X  |w (DE-576)072372613  |x 1432-1041  |7 nnas  |a Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans a placebo-controlled study 
773 1 8 |g volume:62  |g year:2006  |g number:8  |g pages:613-619  |g extent:7  |a Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans a placebo-controlled study 
856 4 0 |u https://doi.org/10.1007/s00228-006-0154-7  |x Resolving-System  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007%2Fs00228-006-0154-7  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211007 
993 |a Article 
994 |a 2006 
998 |g 110903137  |a Mikus, Gerd  |m 110903137:Mikus, Gerd  |d 910000  |d 910100  |d 50000  |e 910000PM110903137  |e 910100PM110903137  |e 50000PM110903137  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 3 
999 |a KXP-PPN1772741833  |e 398509893X 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans","subtitle":"a placebo-controlled study","title_sort":"Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Busse, Dagmar","given":"Dagmar","family":"Busse"},{"role":"aut","display":"Templin, Silke","roleDisplay":"VerfasserIn","given":"Silke","family":"Templin"},{"display":"Mikus, Gerd","roleDisplay":"VerfasserIn","role":"aut","family":"Mikus","given":"Gerd"},{"given":"Matthias","family":"Schwab","role":"aut","display":"Schwab, Matthias","roleDisplay":"VerfasserIn"},{"family":"Hofmann","given":"Ute","roleDisplay":"VerfasserIn","display":"Hofmann, Ute","role":"aut"},{"family":"Eichelbaum","given":"Michel","roleDisplay":"VerfasserIn","display":"Eichelbaum, Michel","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kivistö, Kari T.","given":"Kari T.","family":"Kivistö"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 07.10.2021"],"recId":"1772741833","language":["eng"],"origin":[{"dateIssuedKey":"2006","dateIssuedDisp":"4 July 2006"}],"id":{"doi":["10.1007/s00228-006-0154-7"],"eki":["1772741833"]},"name":{"displayForm":["Dagmar Busse, Silke Templin, Gerd Mikus, Matthias Schwab, Ute Hofmann, Michel Eichelbaum, Kari T. Kivistö"]},"physDesc":[{"extent":"7 S."}],"relHost":[{"origin":[{"dateIssuedKey":"1968","publisher":"Springer","dateIssuedDisp":"1968-","publisherPlace":"Berlin ; Heidelberg ; New York"}],"id":{"eki":["253722829"],"zdb":["1459058-X"],"issn":["1432-1041"]},"name":{"displayForm":["organ of European Association for Clinical Pharmacology and Therapeutics (EACPT)"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"European journal of clinical pharmacology","title_sort":"European journal of clinical pharmacology"}],"pubHistory":["1.1968/69 -"],"part":{"text":"62(2006), 8, Seite 613-619","volume":"62","extent":"7","year":"2006","pages":"613-619","issue":"8"},"titleAlt":[{"title":"Clinical pharmacology"},{"title":"EJCP"},{"title":"Pharmacologia clinica"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans a placebo-controlled studyEuropean journal of clinical pharmacology","note":["Gesehen am 11.10.05"],"recId":"253722829","language":["eng"]}]} 
SRT |a BUSSEDAGMACARDIOVASC4200